David A. Siegel Vascular Biogenics Ltd. Transaction History

Two Sigma Advisers, LP

  • $43.8 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.21 - $0.32 $3,150 - $4,800
15,000 New
15,000 $3,000
Q4 2022

Feb 14, 2023
SELL
$0.11 - $0.16 $1,474 - $2,144
-13,400 Reduced 15.35%
73,900 $8,000
Q3 2022

Nov 14, 2022
BUY
$0.15 - $2.1 $13,095 - $183,330
87,300 New
87,300 $14,000
Q4 2021

Feb 14, 2022
SELL
$1.92 - $2.53 $27,648 - $36,432
-14,400 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$1.94 - $2.55 $27,936 - $36,720
14,400 New
14,400 $30,000

Others Institutions Holding VBLT

# of Institutions
2
Shares Held
416K
Call Options Held
0
Put Options Held
0
View Full List

About Vascular Biogenics Ltd.

VBLT Quotes by TradingView
  • Ticker VBLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,348,896
  • Description
  • Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...
More about VBLT
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email